INTRODUCTION 1
The cell cycle is a dynamic sequence of events leading from one parent cell to two daughter cells. 2 This requires replication of chromosomes during the Synthesis phase (S phase) and their 3 segregation into two daughter cells during Mitosis (M phase). M and S phases are separated by 4 2 Gap phases, G1 and G2, that act as checkpoints to prevent cell division without genome 5 replication and aberrant polyploidy [1] . Progression through cell cycle is regulated by cell cycle 6 stage-specific activation and repression of numerous proteins including Cyclin Dependent 7 Kinases (CDKs) and proteins from the Cyclin family [2] . In most somatic cells, the oscillatory 8 expression or activity of distinct Cyclin-Cdk complexes allows the activation and repression of cell 9 cycle regulators and promotes cell-cycle transitions [2] . One key regulator of this process is the 10 retinoblastoma protein (RB) that controls G1 and prevents entry into S phase. Upon entrance in 11 G1, RB is unphosphorylated (active) and blocks the expression of genes required for G1/S 12 transition. During G1, RB is phosphorylated and becomes inactive, allowing cells to progress to 13 S phase [3] . In embryonic stem cells (ESCs), RB is hyperphosphorylated, resulting in suppression 14 of the G1-S checkpoint and thereby rapid shuttling between DNA synthesis and mitosis, 15 decreasing the average duration of the ESC cell cycle [reviewed in [4] ]. 16 These significant adaptations in the ESC cell cycle are important for the maintenance of the 17 embryonic stem cell state and cell fate decisions, as highlighted by the partial overlap between 18 the gene regulatory networks that control the two processes [5] . For example, both Oct4 and 19 Nanog, two core pluripotency factors, control genes involved in cell cycle regulation: in mouse 20 ESCs (mESCs), Oct4 represses the expression of p21, a Cyclin-dependent kinase inhibitor that 21 is expressed in somatic cells but not in embryonic stem cells [6] ; NANOG, whose expression is 22 cell cycle-regulated, controls S-phase entry by regulating the expression of Cdc25C and CDK6 in 23 human ESCs (hESCs) [7] . While the association between cell cycle dynamics and cell state is 24 well established, the molecular mechanisms underlying this connection remain uncharacterized 25 [5] . 26
In addition to proteins, noncoding RNAs, including long intergenic noncoding RNAs (lincRNAs), 27 have also been shown to contribute to cell cycle progression [8] . An example of this is MALAT1, 28 a lincRNA that is frequently upregulated in multiple human cancers [9] . In human fibroblasts, 29 depletion of MALAT1 leads to decreased expression of several genes involved in cell cycle 30 progression and results in G1 arrest. MALAT1 is also involved in splicing of B-Myb, a gene 31 involved in the transcriptional regulation of several mitotic proteins [10] . More recently, the 32 cohesion regulator long noncoding RNA (CONCR) has been found to be necessary for cell cycle 33 progression and DNA replication. CONCR expression is activated by the transcription factor MYC 1 and is upregulated in multiple cancer types [11] . Silencing of CONCR leads to a significant 2 decrease in DNA synthesis. At the molecular level, CONCR physically interacts with DDEA/H-3 boy helicase 11, which ensures the proper separation of sister chromatids during the cell division 4 process. The absence of CONCR leads to the loss of sister chromatid cohesion and affects 5 metaphase [11] . Finally, lincRNA expression is often dysregulated in cancer and the 6 characterization of subsets of cancer-associated lincRNAs highlights their potential roles as cell 7 cycle progression modulators [12, 13] . 8
LincRNAs are also part of the network controlling stem cell fate maintenance and differentiation 9 [14] . Because lincRNA expression is often tissue-specific [15, 16] , in contrast to proteins, we 10 hypothesized they can support cell type-specific activity of ubiquitously-expressed genes and act 11 at the intersection of cell cycle and mESC cell state regulation. The ability of tissues specific 12 noncoding RNAs to modulate the activity of ubiquitously expressed gene was already exemplified 13 by lncSCA7. This lincRNA regulates ATXN7 levels in retinal and cerebellar neurons and 14 contributes to specific degeneration of this cells in SCA7 patients [17] . Additionally, the relative 15 short half-lives of lincRNAs [18, 19] further underscores their potential as modulators of temporally 16 resolved processes such as cell cycle progression. 17
Here, we investigate the contributions of lincRNAs to embryonic stem cell cycle adaptations. 18 19 1 RESULTS 2
LincRNA expression is often cell-cycle regulated. 3
We used publicly-available single-cell RNA-sequencing (scRNAseq) data for 279 mouse 4 embryonic stem cells with known cell cycle stage [20] to assess the extent of cell cycle-regulated 5 lincRNA expression in mouse embryonic stem cells (mESCs). We estimated the expression of 6 protein-coding transcripts and lincRNAs in each of these cells. After excluding cells and genes 7 that failed quality control ( Supplementary Figure 1) we identified 10 487 genes, including 781 8 lincRNAs, whose expression can be robustly detected in 246 cells. As previously shown [20], 9 gene expression patterns in this dataset reflect the cell cycle stages of the individual cells ( Figure  10 1A), supporting its use to identify transcripts whose expression are cell-cycle dependent. Using 11 DEseq2, we identified 638 genes (6.1%) whose expression is significantly different between at 12 least 2 cell cycle stages ( Supplementary table 1 ). The proportion of differentially expressed 13 lincRNAs (n=70, 8.96%) is significantly higher than found for protein-coding genes (n=501, 14 5.51%) (proportions test p-value < 0.05, Figure 1B , Supplementary Table 1 ), indicating that 15 lincRNA expression is more dynamic throughout the mESC cell cycle than is the expression of 16 protein-coding genes. 17
The median expression of mRNAs is roughly 14 times higher than that of lincRNAs 18 (Supplementary Figure 2A ) and steady state abundance can impact the ability to detect 19 differential gene expression, as highlighted by the significantly higher expression (two-tailed 20
Wilcoxon test, p-value< 2x10 -16 ) of genes identified as differentially expressed (Supplementary 21 Figure 2A ). To assess whether lincRNAs' relatively low expression impacts our differential gene 22 expression analysis results, we repeated the analysis by re-quantifying protein-coding gene 23 expression using a subset (1/14) of randomly sampled reads from each library. At this sequencing 24 depth, the median mRNA expression is comparable to that of lincRNAs in the full data 25 (Supplementary Figure 2B ). We repeated expression quantification, quality control, normalization, 26 filtering and differential gene expression analyses using these randomly sampled reads and found 27 that only 60% of the mRNAs found to be differentially expressed using the full data are also 28 differentially expressed when using the down-sampled libraries. This result indicates that the 29 higher proportion of differentially expressed lincRNAs is likely an underestimate due to the limited 30 power to measure their expression using single cell RNA sequencing data. 31
To validate our in silico differential gene expression predictions we used DNA content to sort 32 mESC cells into G1, S and G2/M stages and measured the cell cycle stage expression of 12 33 differentially expressed lincRNAs, including Neat1, and 3 mESC cell cycle protein-coding genes 1 (Ccnb1, Ccnd1 and Ccne1) by quantitative PCR (Figure 1C, Supplementary Figure 3 ). The cell 2 cycle protein coding gene and lincRNA expression patterns measured by qPCR were generally 3 consistent with what was estimated using scRNA sequencing data. The results of this analysis 4 support that despite the relatively low expression of lincRNAs that complicates the accurate 5 estimation of their expression, our differential expression predictions are generally robust. 6 7 Differentially expressed lincRNAs contribute to the regulation of cell cycle progression. 8
Consistent with the role of differentially expressed protein-coding genes in the regulation of cell 9 cycle progression, these genes are significantly enriched (hypergeometric test adjusted p-value 10 < 0.001) in annotations with gene ontology terms such as "cell division" and other related cell-11 cycle processes ( Figure 2A ). Furthermore, 8.8% (44 of 501) of differentially expressed protein-12 coding loci are orthologous to genes previously shown to have a periodic expression throughout 13 the human cell cycle [21], a significant 3.1-fold enrichment relative to all mESC expressed protein-14 coding loci (214, hypergeometric test p-value < 0.05). These results support that genes 15 differentially expressed between cell cycle stages are indeed enriched in cell cycle regulators. 16
The enrichment of cell-cycle related genes amongst those differentially expressed between cell-17 cycle stages suggests that some of the lincRNAs identified here as differentially expressed might 18 also contribute to mESC cell cycle regulation. Most lincRNAs differentially expressed between 19 cell cycle stages were annotated de novo (53 de novo lincRNAs) using mESC RNA sequencing 20 data [22] . We searched the literature for functions of the remaining 17 differentially expressed 21 lincRNAs annotated by ENSEMBL. Of these, only 4 have been previously characterized: Neat1, 22
Malat1, the host transcript for snord93, and miRNA-24 pri-miRNA transcript. Malat1 is a cancer-23 associated lincRNA and has been previously implicated in cell cycle progression. For example, 24
Malat1 is highly expressed during the S and M phases of human Fibroblasts where it controls cell 25 cycle-related processes [10]. Neat1, whose knockdown was recently shown to impair S phase 26 transition [23] has also been frequently associated with cancer and cell cycle progression [24] . 27
Relatively little is known about snord93 but changes in this RNA's levels impact cell proliferation 28
[25], which would be consistent with a role in cell cycle progression. Finally, miRNA-24 post-29 transcriptionally regulates MYC and E2F2, two known cell cycle genes, and changes in its levels 30 impair G1 transition [26] . In conclusion, all of the 4 annotated and characterized lincRNAs we 31 identified as being differentially expressed either have established roles or have been associated 32 with cell cycle progression. 33
Given the paucity of functional annotations for lincRNAs, and to assess broadly the contributions 1 of differentially expressed lincRNAs to the cell cycle, we reasoned that genes that functionally 2 participate in cell cycle regulation should genetically interact with known cell cycle regulators. To 3 first validate this idea, we considered cell cycle phase differentially expressed protein-coding 4 genes not annotated as cell cycle regulators, and found their expression is more often significantly 5 (p < 0.001, Wilcoxon rank sum test) correlated with the expression of annotated cell-cycle genes 6 than non-differentially expressed protein-coding loci ( Figure 2B ). Similarly, we found that the 7 expression of differentially expressed lincRNAs is also significantly more often correlated with the 8 levels of cell cycle genes than non-differentially expressed lincRNAs ( Figure 2C , p < 0.001 9
Wilcoxon rank sum test), supporting their contributions to mESC cell cycle progression. Hereafter, 10 we refer to differentially expressed lincRNAs and protein-coding genes as cell-cycle associated 11 lincRNAs and protein coding genes, or CC-lincRNAs and CC-PCGs, respectively. 12 13
Cell cycle lincRNAs are associated with stem cell cycle adaptations 14
The cell cycle is a ubiquitous process, yet most lincRNAs are expressed in cell-type specific 15 manner [27] . Do the CC-lincRNAs identified here contribute to cell cycle regulation ubiquitously, 16 or are their functions restricted to mESCs? To gain initial insights into this question we used 17 publicly available transcriptome-wide data [28] to estimate the tissue specificity of lincRNAs and 18 protein coding genes across 29 adult and developing mouse tissue and cell lines. We estimated 19
Tau, a measure of tissue specificity, for CC-lincRNAs, CC-PCGs and known cell cycle regulators. 20 Tau varies between 0% for "ubiquitously expressed" to 100% for "tissue-specifically expressed" 21 genes [29] . As expected, CC-PCGs, as well as established cell-cycle genes, are broadly 22 expressed (median tau=24.8%). In contrast, CC-lincRNAs are significantly more tissue specific 23 (median tau=42%, Wilcox rank sum test p-value < 0.05, Figure 3A ) than their protein-coding 24 counterparts, and are as tissue-specific as other mESC expressed lincRNAs (data not shown). 25
To further test if CC-lincRNA expression is often restricted to mESCs, we investigated changes 26 in their transcript abundance upon neuronal differentiation of mESCs. In vitro neural differentiation 27 is a well-defined and highly efficient process (>80% of differentiated cells). We took advantage of 28 publicly-available transcriptome-wide expression for a time-course of neuronal commitment of 29 mESC [30] to investigate the changes in noncoding and coding gene expression. Consistent with 30 their tissue-specific expression ( Figure 3A ), CC-lincRNA expression decreases rapidly upon 31 differentiation ( Figure 3B ), supporting their contribution to cell cycle regulation being restricted to 32 mESCs. In contrast, CC-PCGs are expressed at similar levels throughout neuronal commitment 1 ( Figure 3C ). 2
The transcriptional network controlling mESC cell state and function is regulated by a set of mESC 3 core transcription factors [31] . The short G1 phase that characterizes the embryonic stem cell 4 cycle, which is critical to ensure maintenance of pluripotency, is in part orchestrated by stem cell-5 specific factors [32] . We took advantage of publicly available data ChIP-seq data for pluripotency 6 transcription factors in mESCs [33] , to assess the extent of these factors' binding of to cell-cycle 7 regulated lincRNA promoters. We found that CC-lincRNA promoters are enriched in mESC core 8 transcription factors (TFs) supporting their role in the network underlying mESC cell state. 9
Specifically, promoters of CC-lincRNAs are significantly enriched, relative to all expressed 10 lincRNAs, in the binding of pluripotency transcription factors, including Nanog, Oct4 and Sox2 11 (FDR<0.05, permutation test) ( Figure 3D ). We found no significant enrichement by most 12 pluripotency TFs at the promotes of CC-PCGs ( Figure 3D ). 13
To assess what aspect of mESC cell cycle progression might be more often modulated by CC-14 lincRNAs, we investigated their relative expression across different cell cycle phases. Consistent 15 with previous observations that mRNA expression peaks at G2/M phase in human cells [34, 35] 16 we found that CC-protein-coding genes were highly expressed in S and G2/M ( Figure 3E ) and 17 were often differentially expressed between G1 vs G2/M ( Figure 3F ). In contrast, the levels of 18 CC-lincRNAs were higher in G1 relative to all other cell cycle stages ( Figure 3E ) and most were 19 differentially expressed between G1 versus S phase ( Figure 3F ). In total, 70% of all CC-lincRNAs 20 are differentially expressed between G1 and another cell cycle stage. 21
Given the significantly elevated expression of CC-lincRNAs in G1, their tissue-specific expression 22 and evidence that their transcription is regulated by stem cell-specific transcription factors, we 23 hypothesized that CC-lincRNAs may contribute to the interplay between cell cycle and 24 maintenance of pluripotency in mESCs. If CC-lincRNAs participate in the network controlling 25 maintenance of mESC cell state, they should be co-expressed with genes involved in 26 maintenance of pluripotency. To test this hypothesis, we investigated the correlation, during 27 mESC neuronal commitment, between CC-genes and genes implicated in maintenance of 28 pluripotency [36] . First, we found that, consistent with the interplay between cell cycle control and 29 maintenance of mESC cell state, the median pairwise correlation between CC-PCGs and 30 pluripotency genes (Spearman's r=0.06) is similar to what is found for pairs of genes implicated 31 in pluripotency (r=0.10, two-tailed Wilcoxon test p-value=0.3, Figure 3G ). Consistent with our 32 hypothesis that CC-lincRNAs contribute to maintenance of mESC cell state, we found that the 33 extent of their association with pluripotency genes (r=0.05) is also similar to what we estimate for 1 pairs of genes implicated in pluripotency (two-tailed Wilcoxon test p-value=0.7, Figure 3G ). For 2 comparison, we also estimated the strength of the association with genes involved in pluripotency 3 for non-cell cycle differentially expressed mESC coding (r=0.03) and non-coding (r=-0.01) genes 4 and found this to be significantly lower than that of CC-lincRNAs or CC-mRNAs (two-tailed 5 Wilcoxon test p-value<0.05, Figure 3G ). Similar results are obtained when considering only 6 significant correlations (correlation test p<0.05) between pluripotency gene and coding or 7 noncoding transcripts. 8
These results suggest that CC-lincRNAs modulate specific aspects of mESC cell cycle and may 9 contribute to the regulation of stem cell cycle adaptions. Figure 4A ). We employed CRISPR activation (CRISPRa) to increase endogenous 18 lincRNAs' transcription. For each lincRNA, we designed 2 guide RNAs (gRNA) to target VP160 19 fused dead-Cas9 (dCas9-VP160) [37] to the vicinity of lincRNA promoters. As a control, we 20 designed a non-targeting scrambled gRNA. We transiently co-transfected each of the gRNA-21 expressing constructs with a dCas9-VP160 expressing vector. Seventy-two hours post-22 transfection we observed an average 2-fold upregulation (2-tailed unpaired t-test p-value < 0.05) 23 of candidate lincRNAs expression ( Figure 4B Figure 4C ). We found that, consistently with the proposed role of 30 lincCC1 and lincCC2 in the modulation of cell cycle progression, upregulation of these lincRNAs 31 is associated with significant changes in the proportion of cells within different cell cycle stages. 32 LincCC1 upregulation is associated with a significant increase in the number of cells in G2/M and 33
small, yet significant changes in the proportion of cells in G1 and S phases ( Figure 4D ). LincCC2 1 mostly affects the proportion of cells in G1. We have also investigated changes in cell cycle 2 markers, specifically Ccnb1 and Ccnd1, whose expression in mESC is highest in G2/M and lowest 3 in G1. As expected, we found that lincCC1 upregulation is associated with a significant increase 4 in the two cell cycle markers ( Figure 4E cycle, which is characterized by a truncated G1 phase, as a model system to assess the 20 contributions of lincRNAs expressed in mESCs to the modulation of this stem cell adaptation. 21
To identify lincRNAs that are putative cell cycle regulators, we reasoned that for noncoding genes 22 the functional moiety is the transcript, thus differential noncoding gene expression between cell 23 cycle stages would result in differential activity and enrich for lincRNAs with roles in cell cycle 24 regulation. Consistent with this hypothesis, our genome-wide analyses and experimental 25 validations support the role of lincRNAs differentially expressed between mESC cell cycle stages 26 as modulators of cell cycle progression, likely through interaction with other cell cycle regulators. 27
Interestingly and relative to protein-coding genes, whose activity during cell cycle is often 28 modulated by post-translational modifications, lincRNAs are enriched among differentially 29 expressed transcripts, supporting that in mESCs their expression is more frequently dynamic 30 throughout cell cycle progression. The fraction of cell cycle-regulated lincRNAs is similar to a 31 previous estimate done in HeLa cells using bulk RNA sequencing (~9%, [39] ). However, the 32 dynamics of lincRNA expression throughout the cell cycle differs between cell types, as in contrast 33 with this earlier study in HeLa [39] that revealed no preferential cell stage specific expression in 1 mESCs, we found most lincRNA are highly expressed in G1 and differentially expressed between 2 G1 and S phase. Given the critical importance of the G1-S transition in maintenance of embryonic 3 stem cell state [32], we hypothesize that a subset of lincRNAs with roles in mESC cell cycle 4 progression also have roles in maintenance of stem cell state. Supporting this hypothesis is the 5 observation that these lincRNAs' expression is often restricted to pluripotent cells, and rapidly 6 decreases upon exit from pluripotency and entry into neural commitment. Furthermore the 7 expression of these lincRNAs is often regulated by core pluripotency transcription factors, 8
including Nanog, Sox2 and Oct4. Finally, we provide preliminary evidence that cell cycle lincRNAs 9 are part of the network underlying pluripotency. Basic cell-level quality control was performed as previously described [20] . Briefly, 17 we excluded cells: 1) with a cell-wise gene detection rate below 20%; 2) cells with <1.6M total 18 hits; 3) cells with proportions of hits to ERCCs lower than 15% or higher than 65%; 4) cells with 19 a proportion of hits to mitochondrial genes lower than 1% or higher than 10%; and 5) cells with 20 an estimated cell size higher or lower than 2 median absolute deviations from the stage-median 21 cell size. In total, after these filtering steps, 94/95 G1 cells, 76/88 S cells, and 74/96 G2/M cells 22 were retained for further analysis. 23
We then performed gene-level quality control. We considered only genes that had at least one hit 24 count in at least 4% of samples. Hit counts were normalized using the scran package (v1.0.4, 25 [43] ). Size factors were calculated using pools of samples of sizes 10 to 35 cells from each stage. 26
We used scLVM [20, 44] to filter out genes whose total variance is not significantly higher than 27 that expected from pure technical variability (fitTechnicalNoise parameters: mincv2=0.01, 28 quan=0.10 ; getVariableGenes parameters: threshold = 0.10, minBiolDisp = 0.30), and 29 subsequently also removed ERCCs & mitochondrial genes. After this final filtering step, 10,487 30 genes were kept. 31
Except for differential expression analysis, where scran-normalised counts were used, all 1 subsequent analyses were performed on scran-normalised shifted log10 counts (sl10 = 2 log10(normalised counts + 1)). In order to assess whether the overall lower expression of lincRNAs affected our ability to call 21 them as DE, we performed a down-sampling experiment to bring mRNA expression down to 22 levels comparable to lincRNAs. We first estimated the average scaling factor between mRNA and 23 lincRNA expression in the original data. We estimated the difference between the median 24
Transcripts Per Million reads (TPM) in quality-controlled cells between lincRNAs and mRNAs to 25 be 14.196, i.e. on average mRNAs are 14x more highly expressed than lincRNAs. We randomly 26 sub-sampled the original FASTQ files to 1/14th of their original size (i.e. using a factor of 0.0714) 27 using seqtk (v 2015.10.15). We quantified transcript expression using Kallisto and filtered cells 28 and genes as described above prior to differential gene expression analysis. For the sub-sampled 29
data, the number of tested genes was similar to the full data (9 923 vs 10 391). We then counted 30 the number of mRNA genes called as DE in the full analysis that passed the quality control filters 31 for the sub-sampled data (388), and the number of those called as DE in the sub-sampled analysis 1 (233, i.e. 60.1%). 
Loci tissue specificity metrics in Mouse 2
We manually selected 150 Mouse paired-end total RNA bulk RNA-sequencing datasets from the 3 ENCODE project [51], covering a range of tissues, sexes and ages, and added 3 publicly-4 available Mouse embryonic stem cell datasets [22] . We defined a "tissue.simple" grouping of 5 samples, based on a high-level description of the tissue of origin (e.g. central nervous system, or 6 heart) and of the developmental stage (adult or embryonic). Gene expression was estimated 7 using Kallisto and imported into R using tximport as described above. Library size normalization 8 was performed with DESeq2, and counts were transformed into shifted log10 normalised values. 9
Values below a background level of 0.1 were set to 0. This cut-off was obtained based on the 10 distribution of shifted log10 expression values. Genes with no expression values above 0 in any 11 sample were discarded. Expression values were averaged across technical and biological 12 replicates using the median. Tau was calculated as described in [29] , briefly as Tau = sum(1-13 
Analysis of cell cycle stage gene expression 24
We resuspended 10 6 cells in 1 ml of PBS, containing 1 uL/mL of fluorescent reactive dye 25 (LIVE/DEAD) and incubated in the dark for 30 minutes at room temperature. Cells were then 26 washed with PBS, spun, and resuspended in fresh medium. We add 2 uL of DNA Hoechst 33324 27 dye (20 mM) and cells were incubated at 37ºC for 20 minutes. Following incubation, cells were 28 centrifuged at 4ºC for 4 minutes at 400 g and the resulting cell pellet was resuspended in 500 ul 29 of 3% FBS in PBS with 0.1% EDTA and kept on ice. Unstained and single dye controls prepared 30 in parallel were used for FACS calibration. 31 Cells were sorted in an AstriosEQ (Beckmann Coulter) cell sorter and collected in 500 uL of RTL 1 buffer from the RNAeasy extraction kit (QIAGEN). Forward and side scatter (FSC & SSC, 488nm 2 DPSS laser) were used as is common for size and doublet exclusion. We excluded dead cells 3 based on LIVE/DEAD fluorescence (488nm DPSS laser) and used DNA content (355nm DPSS 4 laser) to define three gates: G1, S and G2/M (Supplementary Figure 5) . We used E-CRISPR [52] to design 2 guide RNA (gRNA) sequences located within 1 kb of lincCC1 14 and lincCC2 promoters respectively. We synthetized oligos containing these sequences and BbsI 15 restriction sites. Annealed oligos were inserted into the pKLV-U6gRNA(BbsI)-PGKpuro2ABFP 16 vector [53] . 17
We seeded 1.5*10 5 E14 cells/well in 6-well plates and allowed cells to grow overnight. We used 18 lipofectamine 2000 (Thermo Fischer) to transfect 1000 ng of gRNA expression vector and 1000 19 ng of pAC95-pmax-dCas9-Vp160-2A-Neo [37] vector into mESC cultures overnight according to 20 manufacturer's instructions. We replaced growth medium 8 hours after transfection to minimize 21 toxicity. Seventy-two hours post transfection one sample was collected for RNA to ensure the 22 efficiency of the over-expression by qPCR; in parallel the other cells were pulsed with 10 uM Edu 23 for 30 minutes in the dark at 37ºC. Cells were washed with 1% BSA in PBS and trypsinized cells. 24
Following a second wash with 1% BSA in PBS, cells were fixed at room temperature, protected 25 from the light for 15 minutes in 100 uL of Click-iT fixative solution. After fixation, cells were washed 26 in 1% BSA in PBS, resuspended in 100 uL of 1x Click-iT saponin-based permeabilization and 27 wash reagent, and incubated at room temperature in the dark for 15 minutes. Following 28 incubation, 500 uL of Click-iT reaction cocktail containing Alexa Fluor 488 Fluorescent Dye Azide 29 were added and samples were incubated at room temperature in the dark for 30 minutes. 
